Capital International Inc. CA Sells 3,885 Shares of Intuitive Surgical, Inc. $ISRG

Capital International Inc. CA reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 58,032 shares of the medical equipment provider’s stock after selling 3,885 shares during the quarter. Capital International Inc. CA’s holdings in Intuitive Surgical were worth $32,867,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Draper Asset Management LLC lifted its stake in shares of Intuitive Surgical by 41.9% in the 4th quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock valued at $2,848,000 after acquiring an additional 1,485 shares during the last quarter. Procyon Advisors LLC lifted its stake in shares of Intuitive Surgical by 787.8% in the 4th quarter. Procyon Advisors LLC now owns 4,794 shares of the medical equipment provider’s stock valued at $2,715,000 after acquiring an additional 4,254 shares during the last quarter. Oppenheimer Asset Management Inc. lifted its stake in shares of Intuitive Surgical by 29.3% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 71,077 shares of the medical equipment provider’s stock valued at $40,255,000 after acquiring an additional 16,119 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Intuitive Surgical by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after acquiring an additional 263,828 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. lifted its stake in shares of Intuitive Surgical by 22.5% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 11,463 shares of the medical equipment provider’s stock valued at $5,127,000 after acquiring an additional 2,102 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Up 0.8%

NASDAQ ISRG opened at $422.06 on Friday. The company has a market capitalization of $149.48 billion, a price-to-earnings ratio of 51.16, a PEG ratio of 3.37 and a beta of 1.46. Intuitive Surgical, Inc. has a twelve month low of $396.68 and a twelve month high of $603.88. The stock has a fifty day simple moving average of $447.24 and a 200 day simple moving average of $501.02.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.81 earnings per share. Research analysts expect that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Bank of America dropped their price target on Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating for the company in a research note on Monday, May 18th. BTIG Research reiterated a “buy” rating and issued a $574.00 price target on shares of Intuitive Surgical in a research note on Wednesday, April 22nd. UBS Group dropped their price target on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research note on Tuesday, March 17th. Jefferies Financial Group dropped their price target on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a research note on Wednesday, April 22nd. Finally, HSBC dropped their price target on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Nineteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $573.63.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 105 shares of the stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares of the company’s stock, valued at $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 7,448 shares of company stock valued at $3,224,404 over the last ninety days. 0.60% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.